Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clostridium difficile-associated diarrhea and colitis.

S F Yassin1, T M Young-Fadok, N N Zein

  • 1Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|July 11, 2001
PubMed
Summary

Clostridium difficile (C. diff) infection causes diarrhea and colitis, often after antibiotic use. Early diagnosis and prevention through judicious antibiotic use and hygiene are key to managing this growing public health concern.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society Recommendations: 2018.

World journal of surgery·2018
Same author

De Novo Autoimmune Hepatitis Following Liver Transplantation.

Transplantation proceedings·2018
Same author

Diverticular colovesical fistula: What should we really be doing?

Techniques in coloproctology·2017
Same author

Letter: the definition of budesonide dependence in microscopic colitis-authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Immune modulator therapy for microscopic colitis in a case series of 73 patients.

Alimentary pharmacology & therapeutics·2017

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Clostridium difficile is a spore-forming bacterium responsible for antibiotic-associated diarrhea and colitis.
  • The incidence and severity of C. difficile infections are increasing, leading to significant medical and economic burdens.
  • While treatable, delayed diagnosis and treatment can result in severe complications, including toxic megacolon.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, treatment, and prevention of Clostridium difficile infections.
  • To highlight the challenges posed by recurrent C. difficile disease.
  • To emphasize the importance of early detection and intervention.

Main Methods:

  • Literature review of Clostridium difficile infection epidemiology, clinical features, and management strategies.

Related Experiment Videos

  • Synthesis of current recommendations for prevention and treatment.
  • Analysis of factors contributing to disease severity and recurrence.

    • Main Results:

    • Clostridium difficile infections present a spectrum from mild diarrhea to severe colitis.
    • Recurrent infections are a significant clinical challenge.
    • Effective prevention relies on limiting broad-spectrum antibiotic use and implementing infection control measures.

    Conclusions:

    • Early diagnosis and prompt treatment of Clostridium difficile infections are crucial for reducing complications.
    • Prevention strategies, including antimicrobial stewardship and hygiene, are paramount.
    • Managing recurrent C. difficile disease requires ongoing research and tailored therapeutic approaches.